How much revenue did Quotient generate this year?
Quotient has achieved a revenue of 72.75 M USD this year.
Quotient Revenue 2024
Quotient Revenue
72.75 M USD
Ticker
QTNT
ISIN
JE00BLG2ZQ72
WKN
A11598
In 2024, Quotient's sales reached 72.75 M USD, a 77.22% difference from the 41.05 M USD sales recorded in the previous year.
The Quotient Revenue history
| YEAR | REVENUE (undefined USD) | GROSS MARGIN (%) |
|---|---|---|
| 2026e | 146.17 | 10,22 |
| 2025e | 102.1 | 14,64 |
| 2024e | 72.75 | 20,54 |
| 2023e | 41.05 | 36,41 |
| 2022 | 38.51 | 38,80 |
| 2021 | 43.38 | 53,72 |
| 2020 | 32.66 | 45,49 |
| 2019 | 29.13 | 40,86 |
| 2018 | 24.73 | 57,66 |
| 2017 | 22.23 | 51,21 |
| 2016 | 18.52 | 47,84 |
| 2015 | 18.41 | 46,99 |
| 2014 | 19.76 | 57,44 |
| 2013 | 14.37 | 50,10 |
| 2012 | 12.22 | 44,76 |
| 2011 | 10.03 | 43,97 |
Quotient Revenue, EBIT, Net Income JE00BLG2ZQ72 · A11598
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Quotient, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Quotient from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Quotient’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Quotient. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Quotient’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Quotient’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Quotient’s growth potential.
Quotient Revenue, EBIT and net profit per share
| Date | Quotient Revenue | Quotient EBIT | Quotient Net Income |
|---|---|---|---|
| 2026e | 146.17 M undefined | -97.56 M undefined | -145.44 M undefined |
| 2025e | 102.1 M undefined | -85.63 M undefined | -115.63 M undefined |
| 2024e | 72.75 M undefined | -76.66 M undefined | -93.76 M undefined |
| 2023e | 41.05 M undefined | -94.37 M undefined | -150.51 M undefined |
| 2022 | 38.51 M undefined | -103.83 M undefined | -125.13 M undefined |
| 2021 | 43.38 M undefined | -82.7 M undefined | -111.03 M undefined |
| 2020 | 32.66 M undefined | -80.39 M undefined | -105.14 M undefined |
| 2019 | 29.13 M undefined | -79.16 M undefined | -106.41 M undefined |
| 2018 | 24.73 M undefined | -69.99 M undefined | -82.34 M undefined |
| 2017 | 22.23 M undefined | -74.06 M undefined | -85.07 M undefined |
| 2016 | 18.52 M undefined | -49.09 M undefined | -33.88 M undefined |
| 2015 | 18.41 M undefined | -29.71 M undefined | -59.06 M undefined |
| 2014 | 19.76 M undefined | -8.89 M undefined | -10.17 M undefined |
| 2013 | 14.37 M undefined | -4.49 M undefined | -4.71 M undefined |
| 2012 | 12.22 M undefined | -3.96 M undefined | -4.47 M undefined |
| 2011 | 10.03 M undefined | -4.1 M undefined | -4.62 M undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2011 | 10.03 M USD | -4.1 M USD | -4.62 M USD |
| 2012 | 12.22 M USD | -3.96 M USD | -4.47 M USD |
| 2013 | 14.37 M USD | -4.49 M USD | -4.71 M USD |
| 2014 | 19.76 M USD | -8.89 M USD | -10.17 M USD |
| 2015 | 18.41 M USD | -29.71 M USD | -59.06 M USD |
| 2016 | 18.52 M USD | -49.09 M USD | -33.88 M USD |
| 2017 | 22.23 M USD | -74.06 M USD | -85.07 M USD |
| 2018 | 24.73 M USD | -69.99 M USD | -82.34 M USD |
| 2019 | 29.13 M USD | -79.16 M USD | -106.41 M USD |
| 2020 | 32.66 M USD | -80.39 M USD | -105.14 M USD |
| 2021 | 43.38 M USD | -82.7 M USD | -111.03 M USD |
| 2022 | 38.51 M USD | -103.83 M USD | -125.13 M USD |
| 2023e | 41.05 M USD | -94.37 M USD | -150.51 M USD |
| 2024e | 72.75 M USD | -76.66 M USD | -93.76 M USD |
| 2025e | 102.1 M USD | -85.63 M USD | -115.63 M USD |
| 2026e | 146.17 M USD | -97.56 M USD | -145.44 M USD |
Quotient stock margins JE00BLG2ZQ72 · A11598
The Quotient margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Quotient. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Quotient.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Quotient's sales revenue. A higher gross margin percentage indicates that the Quotient retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Quotient's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Quotient's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Quotient's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Quotient. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Quotient's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Quotient Margin History
| Quotient Gross margin | Quotient Profit margin | Quotient EBIT margin | Quotient Profit margin |
|---|---|---|---|
| 2026e | 38.8 % | -66.75 % | -99.5 % |
| 2025e | 38.8 % | -83.87 % | -113.24 % |
| 2024e | 38.8 % | -105.37 % | -128.89 % |
| 2023e | 38.8 % | -229.9 % | -366.64 % |
| 2022 | 38.8 % | -269.58 % | -324.89 % |
| 2021 | 53.72 % | -190.64 % | -255.96 % |
| 2020 | 45.49 % | -246.16 % | -321.96 % |
| 2019 | 40.86 % | -271.71 % | -365.25 % |
| 2018 | 57.66 % | -282.99 % | -332.92 % |
| 2017 | 51.21 % | -333.19 % | -382.73 % |
| 2016 | 47.84 % | -265.06 % | -182.94 % |
| 2015 | 46.99 % | -161.38 % | -320.8 % |
| 2014 | 57.44 % | -44.99 % | -51.47 % |
| 2013 | 50.1 % | -31.25 % | -32.78 % |
| 2012 | 44.76 % | -32.41 % | -36.58 % |
| 2011 | 43.97 % | -40.88 % | -46.06 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2011 | 43.97 % | -40.88 % | -46.06 % |
| 2012 | 44.76 % | -32.41 % | -36.58 % |
| 2013 | 50.1 % | -31.25 % | -32.78 % |
| 2014 | 57.44 % | -44.99 % | -51.47 % |
| 2015 | 46.99 % | -161.38 % | -320.8 % |
| 2016 | 47.84 % | -265.06 % | -182.94 % |
| 2017 | 51.21 % | -333.19 % | -382.73 % |
| 2018 | 57.66 % | -282.99 % | -332.92 % |
| 2019 | 40.86 % | -271.71 % | -365.25 % |
| 2020 | 45.49 % | -246.16 % | -321.96 % |
| 2021 | 53.72 % | -190.64 % | -255.96 % |
| 2022 | 38.8 % | -269.58 % | -324.89 % |
| 2023e | 38.8 % | -229.9 % | -366.64 % |
| 2024e | 38.8 % | -105.37 % | -128.89 % |
| 2025e | 38.8 % | -83.87 % | -113.24 % |
| 2026e | 38.8 % | -66.75 % | -99.5 % |
Quotient Aktienanalyse
What does Quotient do?
Quotient Ltd is a biopharmaceutical company headquartered in Eysins, Switzerland. The company was founded in 2007 with the aim of developing innovative technologies in the field of Personalized Medicine. This means that medications and therapies are specifically tailored to the individual needs of patients. Thanks to state-of-the-art production processes, products can be produced quickly and safely. Quotient Ltd has a unique business model based on transfusion technology. This technology allows the company to produce medications quickly and accurately. The different components of the medications are separated and then combined in the required dosage. This means that the medications can be precisely dosed and the risks of side effects minimized. A key focus of Quotient Ltd is the development of therapeutics. Personalized medicine and the fast and safe production of medications are at the center of this area. The transfusion technology enables medications to be produced quickly and flexibly, which is particularly important for rare diseases and personalized therapies. Another important area is the development of diagnostics. These enable diseases to be diagnosed quickly and safely. Based on this diagnosis, suitable therapies are then developed. Quotient Ltd also relies on transfusion technology for this, which enables fast, reliable, and flexible production of diagnostics. In addition to its developed technology and know-how, Quotient Ltd also has its own production facility. Here, all products are produced to the highest standards. The production facility covers an area of approximately 6,000 square meters. The modern facility is equipped with the latest technologies and meets the highest quality standards. Quotient Ltd offers a variety of products, with a special focus on personalized medicine and the fast and safe production of medications and diagnostics. One example is the PDA diagnostic system, which was developed for the fast and accurate diagnosis of autoimmune diseases. The MosaiQ system is another important product that enables fast and reliable production of medications. The success story of Quotient Ltd is closely linked to the development of transfusion technology. The company has succeeded in developing a technology that allows for the fast and safe production of personalized medicine. This technology has made Quotient Ltd a leading company in the field of personalized medicine worldwide. Today, Quotient Ltd employs over 700 people who are constantly working on the further development of personalized medicine and transfusion technology. Quotient ist eines der beliebtesten Unternehmen auf Eulerpool.com.Revenue Details
Understanding Quotient's Sales Figures
The sales figures of Quotient originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.
Year-to-Year Comparison
Analyzing Quotient’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.
Impact on Investments
Investors often scrutinize Quotient's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.
Interpreting Sales Fluctuations
Increases in Quotient’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.
Frequently Asked Questions about Quotient stock
How much was the turnover of the company Quotient compared to the previous year?
The revenue of Quotient has increased by 77.22% increased compared to the previous year.
What does revenue mean for investors?
The revenue of a company is an important indicator of its financial performance and attractiveness for investors.
Which factors influence the revenue of Quotient?
The revenue of Quotient is influenced by various factors, including the demand for its products and services, market conditions, and prices.
How is the revenue of Quotient measured?
Revenue is typically measured in units referring to the sale of goods and services provided by the company.
How does an increase in sales affect investments?
An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.
What are the possible risks associated with a declining revenue?
A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.
Why is the sales revenue of Quotient so important for investors?
The revenue of Quotient is an important indicator of financial performance and attractiveness for investors.
What strategic measures can a company take to increase revenue?
A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.
How much dividend does Quotient pay?
Over the past 12 months, Quotient paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Quotient is expected to pay a dividend of 0 USD.
What is the dividend yield of Quotient?
The current dividend yield of Quotient is .
When does Quotient pay dividends?
Quotient pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Quotient?
Quotient paid dividends every year for the past 0 years.
What is the dividend of Quotient?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Quotient located?
Quotient is assigned to the 'Health' sector.
Wann musste ich die Aktien von Quotient kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Quotient from 9/6/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/6/2024.
When did Quotient pay the last dividend?
The last dividend was paid out on 9/6/2024.
What was the dividend of Quotient in the year 2023?
In the year 2023, Quotient distributed 0 USD as dividends.
In which currency does Quotient pay out the dividend?
The dividends of Quotient are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Quotient
Our stock analysis for Quotient Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Quotient Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
